Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemiaVikas Gupta, Claire Harrison, John Mascarenhas et al.|Blood|2025Cited by 7
MDS-1047: RENEW Trial in Progress: A Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate Elritercept in Participants With Transfusion-Dependent Anemia and Lower-Risk Myelodysplastic NeoplasmsRami S. Komrokji, Jen L. Salstrom, Pierre Fenaux et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 0